James needed a treatment proven in studies to manage his advanced prostate cancer.
In 1985, Lupron became the first approved drug in its class for the palliative treatment palliative treatment
Treatment that helps alleviate symptoms rather than cure the disease of advanced prostate cancer.3
For more information, talk with your healthcare provider.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
US-LUPR-190306
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
Please see accompanying Full Prescribing information.
References: 1. LUPRON DEPOT® [package insert]. North Chicago, IL: AbbVie Inc. 2. Data on file. AbbVie Inc. IMS Health, IMS National Prescription Audit; January 2018-December 2018. 3. Orange Book product details for NDA 019010. US Food and Drug Administration website. https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=019010. Accessed February 11, 2019.
US-LUPR-190298